Next report date
Report period
Q2 2024
EPS estimate
0.22EUR
Revenue estimate
240.11 MEUR
151.84 MEUR
898.60 MEUR
27.13 M
About SCHOTT PHARMA AG & CO. KGAA
Sector
Industry
CEO
Andreas Reisse
Website
Headquarters
Mainz
Employees (FY)
4.65 K
Founded
2022
ISIN
DE000A3ENQ51
FIGI
BBG01JFK5NQ2
SCHOTT Pharma AG & Co. KgaA engages in designing drug containment and drug delivery solutions. It offers a wide range of advanced drug containment solutions and delivery systems for inject able drugs that supply to the pharmaceutical and biotechnology industries. SCHOTT Pharma AG also provide services and analytics for the pharmaceutical and biotechnology industries in the area of drug containment and delivery. Its services range from developing novel drug containment solutions and delivery systems, to performing analytical tests, and optimizing fill-and-finish processes, as well as providing sustainability and regulatory support. The company was founded on May 10, 2022 and is headquartered in Mainz, Germany.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 1SXP is 39.74 EUR — it has increased by 1.85% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on XETR exchange SCHOTT PHARMA AG & CO. KGAA stocks are traded under the ticker 1SXP.
SCHOTT PHARMA AG & CO. KGAA is going to release the next earnings report on Jun 27, 2024. Keep track of upcoming events with our Earnings Calendar.
1SXP stock is 2.50% volatile and has beta coefficient of 0.98. Check out the list of the most volatile stocks — is SCHOTT PHARMA AG & CO. KGAA there?
1SXP earnings for the last quarter are 0.23 EUR per share, whereas the estimation was 0.16 EUR resulting in a 41.38% surprise. The estimated earnings for the next quarter are 0.26 EUR per share. See more details about SCHOTT PHARMA AG & CO. KGAA earnings.
SCHOTT PHARMA AG & CO. KGAA revenue for the last quarter amounts to 228.60 M EUR despite the estimated figure of 228.55 M EUR. In the next quarter revenue is expected to reach 231.79 M EUR.
Yes, you can track SCHOTT PHARMA AG & CO. KGAA financials in yearly and quarterly reports right on TradingView.
1SXP stock has risen by 5.69% compared to the previous week, the month change is a 1.38% rise, over the last year SCHOTT PHARMA AG & CO. KGAA has showed a 32.47% increase.
1SXP net income for the last quarter is 45.00 M EUR, while the quarter before that showed 34.70 M EUR of net income which accounts for 29.69% change. Track more SCHOTT PHARMA AG & CO. KGAA financial stats to get the full picture.
Yes, 1SXP dividends are paid annually. The last dividend per share was 0.15 EUR. As of today, Dividend Yield (TTM)% is 0.38%. Tracking SCHOTT PHARMA AG & CO. KGAA dividends might help you take more informed decisions.
Like other stocks, 1SXP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SCHOTT PHARMA AG & CO. KGAA stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 28, 2024, the company has 4.65 K employees. See our rating of the largest employees — is SCHOTT PHARMA AG & CO. KGAA on this list?
We've gathered analysts' opinions on SCHOTT PHARMA AG & CO. KGAA future price: according to them, 1SXP price has a max estimate of 45.00 EUR and a min estimate of 30.00 EUR. Read a more detailed SCHOTT PHARMA AG & CO. KGAA forecast: see what analysts think of SCHOTT PHARMA AG & CO. KGAA and suggest that you do with its stocks.